Spire Healthcare Group PLC (SPI) To Go Ex-Dividend on November 16th

Spire Healthcare Group PLC (LON:SPI) announced a dividend on Thursday, September 14th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, November 16th will be paid a dividend of GBX 1.30 ($0.02) per share on Tuesday, December 12th. This represents a dividend yield of 0.5%. The ex-dividend date of this dividend is Thursday, November 16th. The official announcement can be viewed at this link.

Shares of Spire Healthcare Group PLC (LON:SPI) opened at GBX 299.22 ($3.94) on Wednesday. Spire Healthcare Group PLC has a one year low of GBX 218.20 ($2.87) and a one year high of GBX 371.10 ($4.88).

Spire Healthcare Group PLC (LON:SPI) last released its earnings results on Thursday, September 14th. The company reported GBX 8.70 ($0.11) EPS for the quarter, beating the consensus estimate of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). Spire Healthcare Group PLC had a net margin of 1.85% and a return on equity of 1.71%. The firm had revenue of £481 million for the quarter.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Markets Daily and is the property of of Markets Daily. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2017/11/15/spire-healthcare-group-plc-spi-to-go-ex-dividend-on-november-16th.html.

SPI has been the topic of several recent research reports. Numis Securities Ltd reiterated an “add” rating and set a GBX 341 ($4.49) target price on shares of Spire Healthcare Group PLC in a research report on Monday, October 23rd. Liberum Capital downgraded shares of Spire Healthcare Group PLC to a “hold” rating and cut their target price for the stock from GBX 400 ($5.26) to GBX 370 ($4.87) in a research report on Wednesday, July 19th. Jefferies Group LLC cut their target price on shares of Spire Healthcare Group PLC from GBX 350 ($4.60) to GBX 259 ($3.41) and set a “hold” rating on the stock in a research report on Monday, September 25th. Berenberg Bank reiterated a “hold” rating and set a GBX 270 ($3.55) target price on shares of Spire Healthcare Group PLC in a research report on Thursday, September 21st. Finally, J P Morgan Chase & Co cut their target price on shares of Spire Healthcare Group PLC from GBX 376 ($4.95) to GBX 339 ($4.46) and set a “neutral” rating on the stock in a research report on Friday, September 15th. One analyst has rated the stock with a sell rating and six have issued a hold rating to the stock. The company has an average rating of “Hold” and an average target price of GBX 304.14 ($4.00).

In other news, insider Justin Ash purchased 89,100 shares of the company’s stock in a transaction dated Friday, September 29th. The shares were purchased at an average price of GBX 224 ($2.95) per share, for a total transaction of £199,584 ($262,506.91).

About Spire Healthcare Group PLC

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Dividend History for Spire Healthcare Group PLC (LON:SPI)

Receive News & Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply